Cargando…
Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136948/ https://www.ncbi.nlm.nih.gov/pubmed/32272196 http://dx.doi.org/10.1016/j.clim.2020.108414 |
| _version_ | 1783518345668067328 |
|---|---|
| author | Dal Moro, Fabrizio Livi, Ugolino |
| author_facet | Dal Moro, Fabrizio Livi, Ugolino |
| author_sort | Dal Moro, Fabrizio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7136948 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71369482020-04-07 Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology Dal Moro, Fabrizio Livi, Ugolino Clin Immunol Article Elsevier Inc. 2020-05 2020-04-06 /pmc/articles/PMC7136948/ /pubmed/32272196 http://dx.doi.org/10.1016/j.clim.2020.108414 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Dal Moro, Fabrizio Livi, Ugolino Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology |
| title | Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology |
| title_full | Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology |
| title_fullStr | Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology |
| title_full_unstemmed | Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology |
| title_short | Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology |
| title_sort | any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe covid19 infections? a lesson from urology |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136948/ https://www.ncbi.nlm.nih.gov/pubmed/32272196 http://dx.doi.org/10.1016/j.clim.2020.108414 |
| work_keys_str_mv | AT dalmorofabrizio anypossibleroleofphosphodiesterasetype5inhibitorsinthetreatmentofseverecovid19infectionsalessonfromurology AT liviugolino anypossibleroleofphosphodiesterasetype5inhibitorsinthetreatmentofseverecovid19infectionsalessonfromurology |